Evidence map›Paper›PMID 36441790›Full record

ArticlePLoS pathogens2022

Genomic changes in Kaposi Sarcoma-associated Herpesvirus and their clinical correlates.

Jan Clement Santiago, Scott V Adams, Andrea Towlerton, Fred Okuku, Warren Phipps, James I Mullins

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jan Clement SantiagoDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0001-9528-8366
Scott V AdamsFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Andrea TowlertonFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Fred OkukuUganda Cancer Institute, Kampala, Uganda.
Warren PhippsFred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
James I MullinsDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-4461-8158
University of Washington · USFred Hutch Cancer Center · USUganda Cancer Institute · UG

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Project 3U54CA190146 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CASPER, COREY, OREM, JACKSON · 2014 to 2019
$4.1M
Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to TreatmentK23CA150931 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PHIPPS, WARREN · 2011 to 2015
$714k
NCI NIH HHS K23 CA150931NCI NIH HHS U54 CA190146NIAID NIH HHS P30 AI027757
6 · The paper itself

Abstract

Kaposi sarcoma (KS), a common HIV-associated malignancy, presents a range of clinicopathological features. Kaposi sarcoma-associated herpesvirus (KSHV) is its etiologic agent, but the contribution of viral genomic variation to KS development is poorly understood. To identify potentially influential viral polymorphisms, we characterized KSHV genetic variation in 67 tumors from 1-4 distinct sites from 29 adults with advanced KS in Kampala, Uganda. Whole KSHV genomes were sequenced from 20 tumors with the highest viral load, whereas only polymorphic genes were screened by PCR and sequenced from 47 other tumors. Nine individuals harbored ≥1 tumors with a median 6-fold over-coverage of a region centering on K5 and K6 genes. K8.1 gene was inactivated in 8 individuals, while 5 had mutations in the miR-K10 microRNA coding sequence. Recurring inter-host polymorphisms were detected in K4.2 and K11.2. The K5-K6 region rearrangement breakpoints and K8.1 mutations were all unique, indicating that they arise frequently de novo. Rearrangement breakpoints were associated with potential G-quadruplex and Z-DNA forming sequences. Exploratory evaluations of viral mutations with clinical and tumor traits were conducted by logistic regression without multiple test corrections. K5-K6 over-coverage and K8.1 inactivation were tentatively correlated (p<0.001 and p = 0.005, respectively) with nodular rather than macular tumors, and with individuals that had lesions in ≤4 anatomic areas (both p≤0.01). Additionally, a trend was noted for miR-K10 point mutations and lower survival rates (HR = 4.11, p = 0.053). Two instances were found of distinct tumors within an individual sharing the same viral mutation, suggesting metastases or transmission of the aberrant viruses within the host. To summarize, KSHV genomes in tumors frequently have over-representation of the K5-K6 region, as well as K8.1 and miR-K10 mutations, and each might be associated with clinical phenotypes. Studying their possible effects may be useful for understanding KS tumorigenesis and disease progression.

Indexed as

Herpesvirus 8, HumanNeoplasmsGenomicsHumansUganda

Identifiers

PMID36441790
PMCPMC9731496
OpenAlexW4310149607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.